Calgary, Canada

Ewelina B Kulikowski

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ewelina B. Kulikowski: Innovating Therapeutic Solutions in Calgary

Introduction

Ewelina B. Kulikowski is a prominent inventor based in Calgary, Canada, known for her significant contributions to the field of medicine through her innovative therapeutic methods. With a remarkable portfolio of three patents, she has dedicated her career to addressing complement-associated diseases, showcasing her commitment to advancing healthcare solutions.

Latest Patents

Ewelina’s latest patents focus on "Compositions and therapeutic methods for the treatment of complement-associated diseases." This invention outlines groundbreaking methods for modulating the complement cascade in mammals, aiming to treat and prevent various diseases linked to the complement pathway. The invention emphasizes the administration of specific compounds, including 2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one or its pharmaceutically acceptable salts. Ewelina's work in this domain promises to impact the field of therapeutic development significantly.

Career Highlights

Ewelina currently works at Resverlogix Corporation, a company dedicated to developing new therapeutic solutions. Her innovative approaches have positioned her as a leading figure in the field of biomedical research and development. Over the years, she has contributed to numerous research initiatives, focusing on improving treatment methodologies for serious health conditions.

Collaborations

In her professional journey, Ewelina has collaborated with notable colleagues such as Henrik C. Hansen and Dean E. Gilham. These collaborations reflect her ability to work effectively in teams, fostering an environment of shared knowledge and creativity in research and development.

Conclusion

Ewelina B. Kulikowski stands out as a dedicated inventor whose work is paving the way for new therapeutic advancements. Her dedication to modulating complement-associated diseases through innovative methods underscores the importance of research in improving healthcare solutions. As she continues her work at Resverlogix Corporation, her contributions are sure to leave a lasting impact on the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…